Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Whyte Chemicals was a leading independent distributor of specialty chemicals and pharmaceutical ingredients based in the United Kingdom. The company provided a wide range of products including active pharmaceutical ingredients (APIs), excipients, and chemicals for the food, polymer, and surface coating industries. At its peak, it was one of the largest privately owned chemical distributors in the UK, operating extensive warehouse and laboratory facilities. The company played a critical role in the pharmaceutical supply chain, sourcing materials globally for UK-based manufacturers. In 2018, the company entered administration following a period of financial difficulty. Its distribution business and key assets were subsequently acquired by the global specialty chemicals group Azelis, ensuring continuity for its customer base.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Whyte Chemicals.